Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | +6.48% | -1.29% | +37.15% |
Evolution of the average Target Price on X4 Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering X4 Pharmaceuticals, Inc.
HC Wainwright | |
B. Riley | |
Stifel Nicolaus | |
Oppenheimer | |
Cantor Fitzgerald | |
Piper Sandler | |
Canaccord Genuity |
EPS Revisions
- Stock Market
- Equities
- XFOR Stock
- Consensus X4 Pharmaceuticals, Inc.